Search: ISMPP West 2019 Faculty
Results 1 - 3 of 3

Margaret Gordon

Client Solutions Portfolio Director, Client Solutions
Envision Pharma Group

Type of Company:
Communications Agency
CMPP Certified: (9/2017)

Bio: Margaret Gordon has worked in medical communications for over 15 years, leading teams to develop multi-channel strategies and tactics across a wide range of therapeutic areas for large and small pharmaceutical and biotech companies. Motivated to make a difference for patients by making critical information more accessible, Margaret has gained extensive experience in the development of plain language summaries of publications. As a part of her organization¿s Envision the Patient team, Margaret provides consultancy to clients and colleagues to identify, generate and integrate SOPs and best practice guidelines for plain language summaries and patient initiatives. She has co-authored several ISMPP publications on these initiatives. Margaret is a Client Solutions Portfolio Director at Engage Scientific Solutions, part of the Envision Pharma Group. In this role, she leads a cross-functional team supporting multiple fast-paced oncology accounts. Prior to her joining Envision, Margaret held positions specializing in both payer marketing and pharmaceutical sales training. She has served on the ISMPP Certification Board Nominating Committee (2019-2020) and is a certified ISMPP CMPP since 2017. She holds a Bachelor of Arts degree from the University of Kansas.

Gay Grossman

Professional Degrees: BA/BS

Bio: Gay has been active in the Rare Disease community for over two decades and continues her efforts to build and support patient and family advocacy. She co-founded, the foundation for ADCY5-related dyskinesia. supports world-renowned researchers who study the gene and its variant. She continues to build a community of hundreds with this disease, when they started with only 1. She is an advocate of shared data and patients owning their data. Her focus remains to help all Rare Disease patients. Together with her daughter Lilly, she co-authored a children's Rare Disease book, We Are All Rare, providing a Rare Disease learning tool for elementary school aged children. Early in her career, Gays success at Glaxo Inc., provided her with an introduction to science that she now applies when sharing the burden of disease, to bring awareness through advocacy, and public speaking. Gay successfully advocates in a variety of environments including, but not limited to, educational classrooms, private, state, and federal insurance, as well as collaborating in the Rare Disease space to gain access to clinical trials and medical therapies. She is currently the Director of Patient Engagement at Neurogene Inc. and applies her learning to help other Rare Disease families.

Lauren Hunt

Associate Publisher, Journals STM, Editorial
SAGE Publishing

Type of Company:
Professional Degrees: BA/BS, MEd

Bio: Lauren Hunt oversees the US Science, Technology, and Medicine Journals Editorial Department at SAGE Publications. In addition to leadership at SAGE, Lauren manages some of SAGE's highest profile medical journals. She also serves on several committees working as the COPE (Committee on Publication Ethics) and ethics liaison to the editorial department, disseminating industry news to editorial staff. Lauren joined SAGE in 2012 with a Masters Degree in Education and Bachelors degrees in Communications and History from the University of California, Santa Barbara. Prior to SAGE, Lauren taught junior high history in Southern California.